Share page on Facebook Share page on Twitter Share page on LinkedIn Home About ICON ICON in Latin America As a leading CRO with a presence in Latin and Central America since 1998, we have local know-how and site relationships ICON was the first global CRO to establish operations in the region and today is one of the largest. We operate in six countries (Argentina, Brazil, Chile, Colombia, Guatemala, Mexico and Peru), providing in-depth experience, and local expertise, on what is required to contribute to global and regional study delivery. We have the capability and expertise to conduct clinical trials and development projects on both a local, cross-region and global basis and provide the full range of ICON Services. 2,250 Professionals 7 Countries 1998 Year we came to Latin America ICON has broad experience in the implementation of clinical trials in Latin America. We were the first CRO in the region and still one of the largest. This experience enables us to understand and comply with local regulations, customs, and language differences and to efficiently work with the culture and the medical practices in each country of the region– ensuring superior trial compliance and expeditious patient enrolment. It also enables us to provide sound advice to our clients on how to prevent difficulties and delays in the implementation and development of the trials. Why Latin America? Several factors contribute to Latin America being a region of choice to conduct your clinical trials: Patient Access Over 600 million inhabitants and 80% urban population. Large metropolitan areas provide patient concentrations for stronger enrollment Cardiovascular, arthritis, cancer, and infectious diseases are as prevalent as in the United States. Patient compliance and retention - drop-out rates in the region are one-third those of US and EU Strong patient-doctor relationship built upon the health infrastructure of each country. Less competition for patients with fewer clinical trials enrolling compared to US & EU yields superior enrolment rates Lack of Language Barrier Only 2 languages - Spanish and Portuguese. Quality Over the last 10 years, all FDA site inspections conducted on trials with positive results. Market Potential A substantial market for later sale of approved drugs, with registration accelerated by participation in multi-regional clinical trials. We welcome the opportunity to discuss your unique clinical research requirements. IN THIS SECTION Company history ICON in Asia Pacific ICON in Latin America Leadership Quality Environmental, Social & Governance ICON and You Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Contact About ICON Results & Reports For Clients Therapeutics Services Insights Innovation Content Preferences Office locations ICON For Patients Volunteers Investigators Jobs & Careers Investors Suppliers News & Events Press Releases Mediakit Events Social Media Dashboard LinkedIn Twitter Facebook Youtube © 2021 ICON plc Disclaimer Privacy Site Cookies